| European Case Law Identifier: | ECLI:EP:BA:2010:T099609.20100616 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 June 2010 | ||||||||
| Case number: | T 0996/09 | ||||||||
| Application number: | 95911826.6 | ||||||||
| IPC class: | C12N 15/10 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | DNA mutagenesis by random fragmentation and reassembly | ||||||||
| Applicant name: | Maxygen, Inc. | ||||||||
| Opponent name: | GENENCOR INTERNATIONAL INC. Diversa Corporation Koninklijke DSM N.V. Alligator Bioscience AB |
||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Right to be heard violated (yes) Substantial procedural violation (yes) Insufficiently reasoned decision (yes) Remittal to the first instance (yes) Reimbursement of the appeal fee (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090996eu1.html
Date retrieved: 17 May 2021